1. Yao, Kun, He, Leye, Gan, Yu, Long, Zhi, Tan, Jing. 2020. HMGN5 promotes IL-6-induced epithelial-mesenchymal transition of bladder cancer by interacting with Hsp27. In Aging, 12, 7282-7298. doi:10.18632/aging.103076. https://pubmed.ncbi.nlm.nih.gov/32315283/
2. Kitayama, Sachi, Ikeda, Kazuhiro, Sato, Wataru, Inoue, Satoshi, Horie, Kuniko. 2022. Testis-expressed gene 11 inhibits cisplatin-induced DNA damage and contributes to chemoresistance in testicular germ cell tumor. In Scientific reports, 12, 18423. doi:10.1038/s41598-022-21856-3. https://pubmed.ncbi.nlm.nih.gov/36319719/
3. Ma, Quanfeng, Wang, Xiuyu, Wang, Hong, Wang, Qiong, Wang, Jinhuan. 2020. HMGN5 Silencing Suppresses Cell Biological Progression via AKT/MAPK Pathway in Human Glioblastoma Cells. In BioMed research international, 2020, 8610271. doi:10.1155/2020/8610271. https://pubmed.ncbi.nlm.nih.gov/32596388/
4. Su, Boxing, Shi, Bentao, Tang, Yuan, Gao, Xianshu, Zhou, Liqun. 2014. HMGN5 knockdown sensitizes prostate cancer cells to ionizing radiation. In The Prostate, 75, 33-44. doi:10.1002/pros.22888. https://pubmed.ncbi.nlm.nih.gov/25307178/
5. Malicet, Cedric, Rochman, Mark, Postnikov, Yuri, Bustin, Michael. 2011. Distinct properties of human HMGN5 reveal a rapidly evolving but functionally conserved nucleosome binding protein. In Molecular and cellular biology, 31, 2742-55. doi:10.1128/MCB.05216-11. https://pubmed.ncbi.nlm.nih.gov/21518955/
6. Qu, Jintao, Yan, Runmin, Chen, Juxiang, Yan, Yong, Lu, Yicheng. 2011. HMGN5: a potential oncogene in gliomas. In Journal of neuro-oncology, 104, 729-36. doi:10.1007/s11060-011-0558-9. https://pubmed.ncbi.nlm.nih.gov/21373965/
智鼠故事 
